v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 7 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:            
Net loss   $ (7,168,030) $ (4,600,734)   $ (30,986,591) $ (12,897,199)
Adjustments to reconcile net loss to net cash used in operating activities:            
Depreciation   126,504 51,426   172,972 449,700
Operating lease right-of-use assets amortization   281,839 176,001   417,312 383,844
Gain on extinguishment of debt         (1,572,565)
Gain (Loss) on retirement of property, plant, and equipment   (69,513) (775)   78,728 243,913
(Gain) loss on remeasurement of warrant liabilities   725,348 84,811   365,162 (131,244)
Loss on remeasurement of derivative liabilities   (1,306,244)   19,026,449 1,567,737
Amortization of debt issuance costs   66,417 13,315   61,102 4,661
Amortization of debt discount   296,691 1,610,540   4,610,088 2,053,355
Stock-based compensation expense   449,372 361,759   662,448 1,104,446
Changes in Operating Assets and Liabilities:            
Accounts receivable   52,582 (92,648)   (52,561) 249,981
Prepaid expenses and other current assets   (25,703) 90,256   (280,825) 234,449
Other non-current assets   (37,586)   (51,263) 136,000
Accounts payable   12,029 (25,416)   336,096 (50,696)
Accrued expenses   512,270 (30,729)   9,896 (70,770)
Accrued interest payable   130,038 394,285   571,465 669,612
Deferred revenue   145,875 275,170   125,852 (281,944)
Operating lease liabilities   (278,812) (188,451)   (432,851) (366,287)
Net cash used in operating activities   (4,780,679) (3,187,434)   (6,939,086) (6,700,442)
Cash flows from investing activities:            
Purchase of property, plant, and equipment   (405,203) (3,293)   (84,654) (131,340)
Net cash used in investing activities   (405,203) (3,293)   (84,654) (131,340)
Cash flows from financing activities            
Proceeds from convertible notes   6,000,000 400,000   400,000 1,581,192
Proceeds from note payable   2,000,000   4,176,510
Proceeds from issuance of Series B-3 preferred stock, net of debt issuance costs   3,899,698   1,339,364
Common stock issued for options exercised         8,916
Payment of debt issuance fees   (374,591) (21,500)   (21,505) (49,844)
Net cash provided by financing activities   9,525,107 2,378,500   5,903,285 1,531,348
Net change in cash and cash equivalents   4,339,225 (812,227)   (1,120,455) (5,300,434)
Cash and cash equivalents balance, beginning of period   294,411 1,414,866   1,414,866 6,715,300
Cash and cash equivalents balance, end of period $ 4,633,636 4,633,636 602,639   294,411 1,414,866
Supplemental disclosure of cash flow information            
Cash paid for income taxes    
Cash paid for interest   547,866 188,477   498,976 4,744
Supplemental disclosure of non-cash investing and financing activities:            
Right-of-use assets obtained in exchange for lease liabilities         859,310 486,673
Conversion of convertible notes and extinguishment of derivative liability for convertible preferred stock         36,051,826
Extinguishment of warrant liability for convertible preferred stock   5,000,000   839,573
Forgiveness on convertible preferred stock         5,000,000
Warrants issued in connection with notes payable   95,291   506,921
Warrants, net exercised for shares of common stock         80
Conversion of redeemable convertible preferred stock for non-voting common stock   52,732,400      
Embedded derivative discount on convertible notes   2,044,103   $ 86,700
Los Altos Ventures Corp. [Member]            
Cash flows from operating activities:            
Net loss (6,644)     $ (33,623)    
Adjustments to reconcile net loss to net cash used in operating activities:            
Accounts payable and accrued expenses 578     6,700    
Changes in Operating Assets and Liabilities:            
Net cash used in operating activities (6,066)     (26,923)    
Cash flows from financing activities            
Proceeds from Note Payable - Stockholder 15,000     30,000    
Proceeds from issuance of common stock       1,000    
Net cash provided by financing activities 15,000     31,000    
Net change in cash and cash equivalents 8,934     4,077    
Cash and cash equivalents balance, beginning of period 4,077        
Cash and cash equivalents balance, end of period $ 13,011 $ 13,011   $ 4,077